相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance
Adjanie Patabendige et al.
BRAIN RESEARCH (2013)
A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells
Adjanie Patabendige et al.
BRAIN RESEARCH (2013)
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner
Stefan H. Stricker et al.
GENES & DEVELOPMENT (2013)
Ensembl 2012
Paul Flicek et al.
NUCLEIC ACIDS RESEARCH (2012)
Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival
Paer G. Engstroem et al.
GENOME MEDICINE (2012)
Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
Tao Yan et al.
BMC CANCER (2011)
Correlation of Somatic Mutation and Expression Identifies Genes Important in Human Glioblastoma Progression and Survival
David L. Masica et al.
CANCER RESEARCH (2011)
Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells
Natalie Grinshtein et al.
CANCER RESEARCH (2011)
Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies
David Olmos et al.
CLINICAL CANCER RESEARCH (2011)
An Improved Technique for Chromosomal Analysis of Human ES and iPS Cells
Daniela Moralli et al.
STEM CELL REVIEWS AND REPORTS (2011)
Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
Monika Raab et al.
NATURE COMMUNICATIONS (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Transcriptional Profiles of CD133(+) and CD133(-) Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
Claudio Lottaz et al.
CANCER RESEARCH (2010)
An Open-Label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors
Ralf-Dieter Hofheinz et al.
CLINICAL CANCER RESEARCH (2010)
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
Patrick Schoffski et al.
EUROPEAN JOURNAL OF CANCER (2010)
Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Yan Degenhardt et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Klaus Strebhardt
NATURE REVIEWS DRUG DISCOVERY (2010)
HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R
Heidi Dvinge et al.
BIOINFORMATICS (2009)
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Myung Jin Son et al.
CELL STEM CELL (2009)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
Dorothea Rudolph et al.
CLINICAL CANCER RESEARCH (2009)
Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning
Thouis R. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
Surojit Sur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CellProfiler Analyst: data exploration and analysis software for complex image-based screens
Thouis R. Jones et al.
BMC BIOINFORMATICS (2008)
Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture
Yirui Sun et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas
Aiguo Li et al.
MOLECULAR CANCER RESEARCH (2008)
Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
Libor Macurek et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Bmi1 controls tumor development in an ink4a/Arf-independent manner in a mouse model for glioma
Sophia W. M. Bruggeman et al.
CANCER CELL (2007)
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo
Martin Steegmaier et al.
CURRENT BIOLOGY (2007)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Normal cells, but not cancer cells, survive severe Plk1 depletion
XQ Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
Niche-independent symmetrical self-renewal of a mammalian tissue stem cell
L Conti et al.
PLOS BIOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas
KL Ligon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Glioblastomas with an oligodendroglial component: A pathological and molecular study
J He et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Increased human polo-like kinase-1 expression in gliomas
K Dietzmann et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
分享论文
